CGBIO (CEO Yu Hyun-Seung), a specialist in bio-regenerative medicine, announced on the 4th that clinical cases of the adhesive transparent wound dressing ‘EasyDew MD Regen Cream’ were presented at the recently held AMWC Asia in Taiwan. AMWC Asia is the world’s largest academic conference and exhibition in plastic surgery and aesthetic clinics, with over 100 major companies and more than 2,000 global medical professionals participating.
At the event, Professor Park Young-Joon from the Department of Dermatology at Ajou University Hospital attracted attention with his lecture titled ‘Alleviation of subclinical inflammation in xerotic skin by AIMP1-derived peptide containing moisturizer leads to skin barrier recovery.’
Most existing moisturizers focus on ceramide, a lacking component in the epidermis, rather than the cause of skin dryness. However, Professor Park Young-Joon revealed that skin dryness (Xerosis) after laser treatment differs from general chronic dryness in that skin damage is deeper, emphasizing the need for treatment that improves the skin barrier and restores the damaged areas.
Professor Park Young-Joon conducted a study to confirm the efficacy of CGBIO’s EasyDew MD Regen Cream in skin dryness that appeared after laser treatment. The study results showed that the group applying EasyDew MD Regen Cream had significantly lower transepidermal water loss (TEWL) at 2 and 4 weeks compared to the patient group using general moisturizers. Significant improvements were also observed in the Investigator’s Global Assessment (IGA) score and Dermatology Life Quality Index (DLQI). This study marks the first demonstration of EasyDew MD Regen Cream’s efficacy in skin dryness after laser treatment.
EasyDew MD Regen Cream is a wound dressing (Class 2 medical device) used to protect areas where the skin barrier is destroyed, such as dry skin. It restores the skin barrier by consisting of ceramide, free fatty acids, and cholesterol in a 3:1:1 ratio, identical to the skin’s lipid structure. In particular, it contains Neopep-S, a peptide derived from the cell signal-regulating protein (AIMP1) involved in angiogenesis regulation, wound regeneration, and stem cell activation, helping restore the skin barrier rapidly.
Clinical trials conducted at the Korea Institute of Dermatological Sciences proved that EasyDew MD Regen Cream can maintain deep moisturization in the skin for up to 48 hours with a single application and form a stronger skin barrier than before skin damage, minimizing moisture loss. Furthermore, it can be used confidently as it is free from 11 harmful ingredients that can affect the skin and fragrances that can cause allergic reactions.
Professor Park Young-Joon said, “There are many moisturizers on the market, but most of them focus on ceramide, a lacking component in the epidermis, rather than the cause of skin dryness. In the case of skin dryness due to laser treatment, by applying a moisturizer containing the Neopep-S ingredient, we could confirm a rapid and remarkable skin recovery effect after the treatment. This is a differentiated result compared to general moisturizers.”
Mok So-Yoon, the head of the Wound Business Division, said, “EasyDew MD Regen Cream is an MD cream developed based on Neopep-S, and it is differentiated from other products in that it is a moisturizer with clinical evidence of skin recovery after laser treatment. In the future, CGBIO will continue to supply superior products and establish ongoing clinical evidence to become a trusted brand in the skin care field.
▲ Professor Young Joon Park of the Department of Dermatology at Ajou University Hospital giving a presentation at AMWC Asia
▲ ‘Easydew MD Regen Cream’ product image
